Disclaimer - While MedChi does not have a position on medical cannabis, we recognize that some members have decided to recommend cannabis to treat patients in the course of their practice. We recognize that cannabis is a complex and contentious issue and we make no assurances or warranties regarding the below practices of cannabis as a medical tool.
- Medical Cannabis Recommenders in Maryland - A list of physicians that are licensed by the Board of Physicians, licensed by the Maryland Cannabis Commission, are members of MedChi and have asked to be included on this web page. This list is provided to the public who might be interested in seeing a physician regarding cannabis.
- Sale of Unregulated CBD Items in Dispensary Retail Space - Maryland MMCC Bulletin 2019 - 11 Effective July 20, 2019
- Summary of Medical Cannabis Legislation 2019 Legislative Session - May 2019
- First Healthcare Compliance podcast “Medical Cannabis: Legal and Practice Considerations” by Gene M. Ransom III, CEO of MedChi - April 16, 2019
- MedChi Letter to Zirkin and Pendergrass on Regulation of Medical Cannabis - February 8, 2019
- Maryland Medical Cannabis Commission Presentation to the House Health and Government Operations Committee - January 29, 2019
- Maryland Medical Cannabis Commission Legislative Report - Treatment of Opioid Use Disorder with Medical Cannabis January 21, 2019
- Medical Cannabis Task Force Informational Report 1-19 - January 19, 2019
- Letter to Maryland Medical Cannabis Commission re: Proposal Concerning Medical Cannabis Advertising for Providers October 17, 2018
- The Role of Cannabis Legalization in the Opioid Crisis - JAMA Network Journal May 8, 2018
- Epilepsy Drug Made From Marijuana Plant Gets Backing From FDA Staff - Fortune Magazine April 17, 2018
- Maryland Medicine Volume 18, Issue 3 - Medical Cannabis Comes to Maryland: What Physicians Need to Know
- Letter from the U.S. Department of Justice re: Guidance Regarding Marijuana Enforcement
- Medical Cannabis! Are You Covered? - The MedChi Insurance Agency
- Press Release - Governor Larry Hogan Announces Appointments to Natalie M. LaPrade Medical Marijuana Commission
- Maryland Medical Cannabis Commission Webpage
- Maryland Medical Cannabis Law (Updated as of September 2015. Section titles are not part of the law.)
- COMAR (Code of Maryland Regulation) - Subtitle 62 Natalie LaPrade Medical Cannabis Commission
Updates from April 24, 2019
Effective October 1, 2019, the Natalie M. LaPrade Medical Cannabis Commission will be updated in accordance with House Bill 2 which was signed into legislation in 2018. This legislation changes the makeup of the Commission and revises the requirements for membership. A copy of the Bill is attached here for reference.
The Governor's Appointments Office is accepting applications for the following Commission seats (effective 10/1/19):
- Two licensed non-certified providers who are physicians, dentists, podiatrist, nurse practitioners or nurse midwives.
- One nurse or other health care provider experience in hospice, nominated by a State hospice trade association.
- One pharmacist licensed in the State, nominated by a State research institution or trade association; and
- One scientist who has experience in the science of cannabis, nominated by a State research institution
- Four members with substantial experience:
- As an executive with fiduciary responsibilities for a large organization or foundation;
- In an academic field relating to health, agriculture, finance, or addiction treatment; or
- As a professional in a profession relating to health, agriculture, finance, or addiction treatment.
The attached document includes important information on additional requirements for applicants, the Commission's duties, time commitment, and other relevant information. This information should be thoroughly reviewed by interested individuals prior to submission of an application.
Interested applicants must submit a formal application by June 30, 2019 by clicking here.
Update from January 4, 2018
Today the Justice Department repealed the Cole Memo that adopted a policy of non-interference with marijuana-friendly state laws. MedChi is reviewing the information and will provide what, if any, guidance to our members.
On January 4th, AG Jeff Sessions rescinded the Cole Memo and allow federal prosecutors decide how to enforce the federal law, even in the states that have legalized cannabis. It is unclear how this will affect Maryland, as Maryland recently legalized medicinal cannabis
Materials from 3/30/2018 Cannabinoid Breakfast Series Meeting
Materials from 12/15/2017 Medical use of Cannabinoids Series Meeting